[go: up one dir, main page]

DE69820053D1 - Stör-notokord zur verminderung der symptome / behandlung von arthritis - Google Patents

Stör-notokord zur verminderung der symptome / behandlung von arthritis

Info

Publication number
DE69820053D1
DE69820053D1 DE69820053T DE69820053T DE69820053D1 DE 69820053 D1 DE69820053 D1 DE 69820053D1 DE 69820053 T DE69820053 T DE 69820053T DE 69820053 T DE69820053 T DE 69820053T DE 69820053 D1 DE69820053 D1 DE 69820053D1
Authority
DE
Germany
Prior art keywords
arthritis
notocord
interference
treatment
notochord
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69820053T
Other languages
English (en)
Other versions
DE69820053T2 (de
Inventor
Seiji Aoyagi
J Demichele
W Johns
B Mazer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69820053D1 publication Critical patent/DE69820053D1/de
Publication of DE69820053T2 publication Critical patent/DE69820053T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
DE69820053T 1997-07-02 1998-06-23 Stör-notokord zur verminderung der symptome / behandlung von arthritis Expired - Fee Related DE69820053T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US887432 1992-05-21
US08/887,432 US5849336A (en) 1997-07-02 1997-07-02 Method using sturgeon notochord for alleviating the symptoms of arthritis
PCT/US1998/012997 WO1999001147A1 (en) 1997-07-02 1998-06-23 Method and product using sturgeon notochord for alleviating the symptoms of arthritis

Publications (2)

Publication Number Publication Date
DE69820053D1 true DE69820053D1 (de) 2004-01-08
DE69820053T2 DE69820053T2 (de) 2004-08-19

Family

ID=25391113

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69820053T Expired - Fee Related DE69820053T2 (de) 1997-07-02 1998-06-23 Stör-notokord zur verminderung der symptome / behandlung von arthritis

Country Status (9)

Country Link
US (3) US5849336A (de)
EP (1) EP0988043B1 (de)
AT (1) ATE254924T1 (de)
CA (1) CA2294090C (de)
DE (1) DE69820053T2 (de)
DK (1) DK0988043T3 (de)
ES (1) ES2212310T3 (de)
PT (1) PT988043E (de)
WO (1) WO1999001147A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025921A1 (en) * 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
DE19855890A1 (de) * 1998-12-03 2000-06-08 Nerlich Michael Poröse Kompositmatrix, deren Herstellung und Verwendung
US6524609B1 (en) 1999-08-18 2003-02-25 Nutri-Vet, Llc Treating arthritis in animals with dietary supplements
US6579544B1 (en) 2000-05-31 2003-06-17 Nutriex, L.L.C. Method for supplementing the diet
US6358526B1 (en) 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
US6767899B1 (en) * 2000-08-29 2004-07-27 Leiner Health Services Corp. Composition and method for treatment of conditions having an inflammatory component
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease
US7582670B2 (en) * 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
US8563525B2 (en) 2004-01-12 2013-10-22 Natrogen Therapeutics International, Inc. Methods of treating an inflammatory-related disease
US6936686B2 (en) * 2002-12-11 2005-08-30 Nutech Corporation Cross-linked silicone gels; products containing the same; and methods of manufacture thereof
ES2308358T3 (es) * 2005-05-19 2008-12-01 Samsung Electronics Co., Ltd. Teclado y conjunto de teclado.
CN101426268B (zh) * 2007-11-02 2010-08-25 大唐移动通信设备有限公司 导频资源分配方法、系统和设备
JP5043215B1 (ja) * 2011-07-01 2012-10-10 国立大学法人北海道大学 チョウザメ類脊索から簡便な抽出方法で得られるｉｉ型コラーゲン
US10833408B2 (en) 2017-07-07 2020-11-10 Rockwell Collins, Inc. Electronically scanned array
ES2905713A1 (es) * 2020-10-09 2022-04-11 Univ Granada Nuevo biomaterial para ingenieria tisular
CN114766553A (zh) * 2022-05-05 2022-07-22 中国海洋大学 鲟鱼龙筋咀嚼片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
US4925924A (en) * 1984-03-27 1990-05-15 University Of Medicine And Dentistry Of New Jersey Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof
CA1302880C (en) * 1986-07-25 1992-06-09 Peter Koepff Agents for the treatment of arthroses
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5075112A (en) * 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
US5529786A (en) * 1994-02-28 1996-06-25 Moore; Eugene R. Process and product for treatment of rheumatoid arthritis
JPH07250887A (ja) * 1994-03-15 1995-10-03 Seikagaku Kogyo Co Ltd 人工血管およびその製造方法
US5709887A (en) * 1995-06-06 1998-01-20 Bryan, Deceased; Clifford R. Method and composition for treating tumors
US5840848A (en) * 1996-01-05 1998-11-24 Autoimmune, Inc. Method for preparation of type II collagen

Also Published As

Publication number Publication date
HK1028949A1 (en) 2001-03-16
WO1999001147A1 (en) 1999-01-14
US6423347B1 (en) 2002-07-23
DE69820053T2 (de) 2004-08-19
ES2212310T3 (es) 2004-07-16
US5849336A (en) 1998-12-15
CA2294090C (en) 2003-09-16
ATE254924T1 (de) 2003-12-15
EP0988043B1 (de) 2003-11-26
US6149946A (en) 2000-11-21
EP0988043A1 (de) 2000-03-29
CA2294090A1 (en) 1999-01-14
PT988043E (pt) 2004-04-30
DK0988043T3 (da) 2004-04-05

Similar Documents

Publication Publication Date Title
DE69820053D1 (de) Stör-notokord zur verminderung der symptome / behandlung von arthritis
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE265213T1 (de) Noribogain zur behandlung von schmerzen und drogenabhängigkeit
ATE211129T1 (de) Inhibitoren von beta-amyloid-protein-herstellung
PT705100E (pt) Guanidinas substituidas terapeuticas
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ZA98214B (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
GR3026369T3 (en) Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist.
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
DE69426471D1 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
DE69429101D1 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE69526972D1 (de) Verwendung von Gabapentin in der Behandlung vonAngst - und Panikstörungen
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE69821970D1 (de) Verwendung von CITICOLINE ZUR BEHANDLUNG VON MULTIPLER SKLEROSE

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee